Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:TG 59:0)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST003776 AN006202 Investigation of Hepatic Lipid Alterations Following Micro- and Nanoplastic-Ingestion Liver Mouse Environmental exposure University of Bonn LC-MS
ST003614 AN005939 Kupffer cells control neonatal hepatic glucose metabolism via Igf1 signaling - lipidomics analysis of postnatal day 0 murine livers after macropahges depletion Liver Mouse University of Bonn LC-MS
ST003220 AN005280 Obesity, sex, and depot drive distinct lipid profiles in murine white adipose tissue Adipose tissue Mouse Obesity University of Utah LC-MS
ST003051 AN005002 Shotgun lipidomics of breast cancer endocrine therapy persisters Breast cancer cells Human Cancer Dartmouth College LC-MS
ST000917 AN001500 Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 3:Urine Urine Human Fatty liver disease LIPID MAPS GC-MS/LC-MS
ST000915 AN001488 Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 2:Liver Liver Human Fatty liver disease LIPID MAPS GC-MS/LC-MS
ST000665 AN001017 Nonalcoholic fatty liver disease (NAFLD) Studies Cultured cells Human Fatty liver disease University of Michigan LC-MS
ST000662 AN001011 Lipidomics of hormone-sensitive lipase variants Adipose tissue Human University of Michigan LC-MS
ST000005 AN000012 Timecourse on RAW 264.7 cells treated with Kdo2-Lipid A and compactin Macrophages Mouse LIPID MAPS GC-MS/LC-MS
  logo